Smartwatch-Style device could help cancer patients, but first: does it work in healthy people?

NCT ID NCT06366074

Terminated Knowledge-focused Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a wearable device that delivers mild electrical stimulation to the wrist (called transcutaneous electrical acustimulation, or TEA) in healthy adults. Participants wear the device for three days and use it for 60 minutes daily. The goal is to see if the device is easy to use and safe, with no serious skin irritation or pain. This early work is meant to pave the way for future studies in cancer patients who experience symptoms from chemotherapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Watch-Transcutaneous Electrical Acustimulation (TEA) device
What this could lead to: If successful, this device could be tested in cancer patients to help manage chemotherapy-induced symptoms like nausea or pain.
What could go wrong: This is a very early pilot study with no participants enrolled yet. It only tests usability and safety in healthy people, so it may not translate to patient benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Locations

University of Michigan

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.